Reading this on a mobile device? Try our optimized mobile version here:

December 24, 2012News for the transfusion medicine and cellular therapy community

  Top Story 
  • Flu season arrives early in U.S., health officials say
    Flu activity increased last week, with 12 states reporting high flu levels, according to the CDC. New York City and five states reported moderate flu activity, while 33 states reported low activity. The flu season is "off to an early start," but it is too soon to tell how severe the season will be, CDC Director Dr. Thomas Frieden said in a statement. HealthDay News (12/21) LinkedInFacebookTwitterEmail this Story
Certified Quality Auditor Question Bank
Simulate the CQA exam from the convenience of your home or office. ASQ's online certification preparation course teaches you the concepts you'll see on your test, and provides practice exams so you can review the material. This gives you the best chance to learn effectively and pass your exam. All for as little as $99.

  Science & Health 
  • Study links gene to sepsis risk
    A study published in Anesthesiology found that a gene called NFKB may play a role in multiplying inflammation with sepsis. The finding could lead to personalized medication for patients with the gene. (12/21) LinkedInFacebookTwitterEmail this Story
  • Surgical mistakes remain common, study finds
    At least 4,000 surgical errors known as "never events" occur in the U.S. annually, Johns Hopkins University researchers reported in the journal Surgery. Foreign objects are left inside patients about 39 times a week, while the wrong procedure is conducted or the wrong body part is operated on about 20 times per week, researchers estimated. Medical News Today (12/22) LinkedInFacebookTwitterEmail this Story
Patient Blood Management Resources from AABB
AABB offers a host of tools for transfusion decision makers. Clinical guidelines, education sessions and more. AABB Members can download Getting Started in Patient Blood Management and Citations in Patient Blood Management for FREE. Visit for more information.

  Hot Topics 

Top five news stories selected by AABB SmartBrief readers in the past week.

  • Results based on number of times each story was clicked by readers.
  Emerging Trends 
  Industry News & Practice 
  • University of Pittsburgh hospital opens blood cancer facility
    The University of Pittsburgh Medical Center has opened the Mario Lemieux Center for Blood Cancers, which among other goals will streamline participation in clinical trials. "Our focus is to improve the patient experience through the center's design and to bring the latest technology and research from the lab to the bedside so we can ensure we are providing the best care possible," said Dr. Nancy Davidson, director of the University of Pittsburgh Cancer Institute and the UPMC CancerCenter. Pittsburgh Post-Gazette (12/24) LinkedInFacebookTwitterEmail this Story
  Government & Regulatory 
  • FDA warns against use of dabigatran in artificial heart valve patients
    The FDA warned providers against prescribing the anticoagulant Pradaxa, or dabigatran, to prevent stroke or blood clots in patients with artificial heart valves. The agency based its warning on the results of a European clinical trial that found patients with mechanical heart valves taking dabigatran were at greater risk for strokes, clots and heart attacks than patients on warfarin. Patients already taking dabigatran should be immediately moved to another drug, the FDA added. HealthDay News (12/20) LinkedInFacebookTwitterEmail this Story
  • Roche wins FDA OK for wider use of flu drug Tamiflu
    The FDA endorsed the use of Roche Holding's flu treatment Tamiflu, or oseltamivir, for children ages 2 weeks to 1 year who have had symptoms of flu for no more than two days. The drug is not indicated for flu prevention in this age group, according to the agency. Reuters (12/21), HealthDay News (12/21) LinkedInFacebookTwitterEmail this Story
  Association News 
  • AABB requests nominations for 2013, 2014 memorial awards
    AABB is seeking nominations for its 2013 and 2014 memorial awards, which will honor individuals who have advanced the practice of transfusion medicine and cellular therapies. The awards are presented to recognize achievements in administration, immunohematology, quality and innovative research, and overall outstanding service. Individuals are encouraged to nominate candidates by completing and submitting the online nomination form by Jan. 25. Recipients will be honored at the 2013 AABB Annual Meeting in Denver or the 2014 AABB Annual Meeting in Philadelphia. LinkedInFacebookTwitterEmail this Story
Learn more about AABB® ->Homepage  |  Join AABB  |  Conferences  |  Marketplace

  Editor's Note 
  • SmartBrief will not publish Tuesday
    In observance of Christmas, SmartBrief will not publish Tuesday. Publication will resume Wednesday. Enjoy the holiday! LinkedInFacebookTwitterEmail this Story
Position TitleCompany NameLocation
Performance Improvement ConsultantBlood Systems, Inc.US - AZ - Scottsdale
Laboratory ManagerCreative Testing SolutionsUS - IL - Chicago
Quality SpecialistBlood Systems, Inc.US - NV - Las Vegas
Laboratory SupervisorCreative Testing SolutionsUS - IL - Chicago
LABORATORY MANAGERUnited Blood ServicesUS - NV - Las Vegas
QA SpecialistSan Diego Blood BankUS - CA
Reference TechnologistLifeStreamUS - CA - San Bernardino
West Coast Account ManagerMacopharma USAUS - Nationwide
Director, Patient Blood ManagementAABBUS - MD - Bethesda
Click here to view more job listings.

In seed time learn, in harvest teach, in winter enjoy."
--William Blake,
British poet and painter

LinkedInFacebookTwitterEmail this Story

Subscriber Tools
Print friendly format | Web version | Search past news | Archive | Privacy policy

Corporate Relations Manager:  Tamara Zein (240) 333-6604
Job Board: AABB CareerLink
A powerful website for SmartBrief readers including:
 Recent AABB SmartBrief Issues:   Lead Editor:  Tom Parks
Managing Editor: Cristian Becker

Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2012 SmartBrief, Inc.® Legal Information